Summary
Updated Aug 30, 2026
Sridhar Kosaraju files SEC Form 4 reports at 10x Genomics, Inc. (TXG). 2 SEC Form 4 filings on record going back to 2024, most recently on 8 June 2026.
Recent Transactions
2Every recent SEC Form 4 transaction Sridhar Kosaraju has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Sridhar Kosaraju files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Serge Saxonov - $4.79M of TXG open-market activity in the last 12 months
- Adam Taich - $1.84M of TXG open-market activity in the last 12 months
- Benjamin J. Hindson - $1.46M of TXG open-market activity in the last 12 months
- John R. Stuelpnagel - $1.16M of TXG open-market activity in the last 12 months
- Sarah A. Teichmann - $579K of TXG open-market activity in the last 12 months
- Shehnaaz Suliman - $327K of TXG open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Sridhar Kosaraju?
Sridhar Kosaraju is a corporate insider of 10x Genomics, Inc. (TXG). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Sridhar Kosaraju submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Sridhar Kosaraju's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Sridhar Kosaraju and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
